High Long-Term Risk for Recurrence After Acute Lower GI Bleeding (Medscape)

This article discusses the use of the drug “sotagliflozin” in patients with type 2 diabetes. The article reports on the results of a study that found that sotagliflozin was effective in reducing blood sugar levels and body weight in patients with type 2 diabetes who were already taking insulin. The study also found that sotagliflozin was well-tolerated by patients and did not increase the risk of hypoglycemia. The article concludes that sotagliflozin may be a useful treatment option for patients with type 2 diabetes who are already taking insulin and are struggling to control their blood sugar levels.